CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial

Open access

Abstract

BACKGROUND: Lactose intolerance (LI) is a common medical problem with limited treatment options. The primary symptoms are abdominal pain, diarrhea, bloating, flatulence, and cramping. Limiting dairy foods to reduce symptoms contributes to low calcium intake and the risk for chronic disease. Adaptation of the colon bacteria to effectively metabolize lactose is a novel and potentially useful approach to improve lactose digestion and tolerance. RP-G28 is novel galacto-oligosaccharide (GOS) being investigated to improve lactose digestion and the symptoms of lactose intolerance in affected patients. METHODS: A randomized, double-blind, parallel group, placebo-controlled study was conducted at 2 sites in the United States. RP-G28 or placebo was administered to 85 patients with LI for 35 days. Post-treatment, subjects reintroduced dairy into their daily diets and were followed for 30 additional days to evaluate lactose digestion as measured by hydrogen production and symptom improvements via a patient-reported symptom assessment instrument. RESULTS: Lactose digestion and symptoms of LI trended toward improvement on RP-G28 at the end of treatment and 30 days post-treatment. A reduction in abdominal pain was also demonstrated in the study results. Fifty percent of RP-G28 subjects with abdominal pain at baseline reported no abdominal pain at the end of treatment and 30 days post treatment (p = 0.0190). RP-G28 subjects were also six times more likely to claim lactose tolerance post-treatment once dairy foods had been re-introduced into their diets (p = 0.0389). CONCLUSIONS: Efficacy trends and favorable safety/tolerability findings suggest that RP-G28 appears to be a potentially useful approach for improving lactose digestion and LI symptoms. The concurrent reduction in abdominal pain and improved overall tolerance could be a meaningful benefit to lactose intolerant individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2891-12-160

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design.
Figure 1 Study design.CC BY · PubMed Central
Figure 2 Subject disposition.
Figure 2 Subject disposition.CC BY · PubMed Central
Figure 3 Average percent change in patient-reported symptoms between Days 0 and 36. RP-G28 (n = 42). Placebo (n = 20). p = 0.7291
Figure 3 Average percent change in patient-reported symptoms between Days 0 and 36. RP-G28 (n = 42). Placebo (n = 20). p = 0.7291CC BY · PubMed Central
Figure 4 Subjects reporting >50% decrease in abdominal pain (“Responders”). RP-G28 (n = 36). Placebo (n = 19). Subjects with no abdominal pain at baseline were excluded from the analysis. p = 0.0288.
Figure 4 Subjects reporting >50% decrease in abdominal pain (“Responders”). RP-G28 (n = 36). Placebo (n = 19). Subjects with no abdominal pain at baseline were excluded from the analysis. p = 0.0288.CC BY · PubMed Central
Figure 5 Subjects reporting no abdominal pain on Day 36 and 66. RP-G28 (n = 36), Placebo (n = 19), p = 0.0190.
Figure 5 Subjects reporting no abdominal pain on Day 36 and 66. RP-G28 (n = 36), Placebo (n = 19), p = 0.0190.CC BY · PubMed Central
Figure 6 Patient Global Assessment on Day 66 showing percent of subjects claiming lactose tolerance. RP-G28 (n = 40). Placebo (n = 18). p = 0.0389.
Figure 6 Patient Global Assessment on Day 66 showing percent of subjects claiming lactose tolerance. RP-G28 (n = 40). Placebo (n = 18). p = 0.0389.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 99

Metadata

Authors
Savaiano, D. A., Ritter, A. J., Klaenhammer, T. R., James, G. M., Longcore, A. T., Chandler, J. R., Walker, W. A., & Foyt, H. L.
Affiliations
  • Purdue University West Lafayette (US)
  • North Carolina State University (US)
  • University of Southern California (US)
  • Massachusetts General Hospital (US)
Corresponding author
Savaiano, Dennis A
Venue
Nutrition Journal
Published
2013-12
Volume
12
Issue
1
Pages
160-160
ISSN
1475-2891 (ISSN-L)
OpenAlex
W2142455021
Cited by
99
References
21
Citations by year
2026: 7 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 4 · 2014: 1
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • Nutrition Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Purdue e-Pubs (Purdue University System) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Digestive system and related health
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
lactose intolerance, galactooligosaccharides, lactose digestion, abdominal pain, hydrogen breath test, gut microbiota, prebiotics, symptom improvement
MeSH terms
Adult, Colon, Dairy Products, Digestion, Double-Blind Method, Female, Follow-Up Studies, Gastrointestinal Agents, Humans, Intestinal Mucosa, Lactose, Lactose Intolerance, Male, Oligosaccharides, Severity of Illness Index, Trisaccharides, United States, Abdominal Pain, Incidence, Lactase, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. https://app.cochat.ai/papers/10.1186/1475-2891-12-160
The paper
Savaiano, D. A., Ritter, A. J., Klaenhammer, T. R., James, G. M., Longcore, A. T., Chandler, J. R., Walker, W. A., & Foyt, H. L. (2013). Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial. Nutrition Journal. https://doi.org/10.1186/1475-2891-12-160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.